We studied the distribution of microtubule-associated protein 1 A (MAP1 A) in Purkinje cell dendrites by means of electronmicroscopic immunocytochemistry, using a monoclonal antibody (McAb) MAPlA on a nitrocellulose filter through use of the immunoblotting method, and stained immunofluorescently Purkinje cell perikarya, dendrites, and axons. Using the McAb, we labeled rat cerebellum extracted with Triton X-100 and simultaneously fixed with aldehyde, followed by gold-labeled rabbit anti-mouse IgG. Gold particles were attached to the filamentous, fuzzy materials, mostly those connected to microtubules (MTs), but were hardly localized on those attached to neurofilaments (NFs). The 3-dimensional cytoskeletal ultrastructure of fresh Purkinje cell dendrites was revealed by QF-DE. In Purkinje cell dendrites, MT was a predominant cytoskeletal element, whereas only a few NFs were found. Fine, elaborate cross-bridges filled up the interstices among MTs, and between MTs and other cellular components.
Cross-bridges linking MTs to one another were composed mainly of a fine filamentous structure, frequently branching and anastomosing at several sites, and appeared somewhat granular. We ensured that the crossbridges observed in saponin-extracted tissues were not a result of artifactual condensations or precipitations of soluble proteins during deep etching.
The molecular structure of MAPlA was further investigated by the rotary shadowing technique.
The affinity-purified MAPlA was a long, thin, filamentous, and very flexible molecule.
We also studied taxol-stabilized MTs decorated with MAPlA by means of QF-DE. It was shown that MAPlA extended outward from the MT wall as thin filaments connecting MTs to one another. These observations have led to the conclusion that MAPlA is possibly one of the main components of the cross-bridges between MTs in Purkinje cell dendrites.
Neurons are highly polarized cells; that is, they receive stimuli mainly at synaptic sites on dendrites and soma, integrate the stimuli at the dendrites and soma, and initiate and conduct these impulses through the axons. They develop characteristic 3-dimensional structures for this purpose. In this regard, the differentiation of the cytoskeletal organization can be considered as providing a necessary base for the various functions within the nerve cells. It is well known that microtubules (MTs) and neurofilaments (NFs) are basic cytoskeletal elements in nerve cells. In order to understand the differentiated functions in neurons, a prerequisite is the study of both the cytoskeletal structure and the distributions of the chemical components of each part of these cells.
Recently, extensive biochemical and immunofluorescent studies have been carried out in order to characterize these cytoskeletal components and their associated proteins. The microtubule-associated proteins (MAPS) from brain tissue have been characterized and categorized into several classes: highmolecular weight-proteins (MAPl, M, = 350,000; MAP2, M, = 270,000) (Borisy et al., 1975; Sloboda et al., 1975) , a family of closely related lower-molecular-weight proteins ("tau," M, = 55,000-70,000) (Weingarten et al., 1975; Cleveland et al., 1977a, b) , and low-molecular-weight MAPS (Vallee and Davis, 1983) . Among these, MAP1 and MAP2 are the most prominent nontubulin proteins in brain MT preparations. Purified MAP1 (Vallee and Davis, 1983) and MAP2 (Herzog and Weber, 1978; Rim et al., 1979; Gottlieb and Murphy, 1985) have the appearance in vitro of regularly spaced filamentous arms on the MT surface. MAP1 has been further categorized into at least 3 subspecies: MAPlA, MAPlB, and MAPlC (Bloom et al., 1984) . Tau induces the formation of rather smooth MTs, without the arm expression (Weingarten et al., 1975; Herzog and Weber, 1978) . Tubulin itself makes up the structural backbone of the MT. These MAPS show a characteristic subcellular distribution in neurons. MAP1 is distributed widely in various tissues and in both dendritic and axonal processes of neurons (Matus et al., 1983; Bloom et al., 1984; Huber and Matus, 1984) . However, MAP2 is preferentially localized in the dendritic processes of neurons (Miller et al., 1982; Matus et al., 1983; DeCamilli et al., 1984) , and tau is predominantly detected in axons (Binder et al., 1984) .
Until now, little has been known about how these proteins organize in vivo the cytoskeletal architecture at the ultrastructure level. MAP2 has been considered to be associated with intermediate filaments in cultured brain cells (Bloom and Vallee, 1983) and NFs in p, P'-iminodipropionitrile (IDPN)-intoxicated rat axons (Papasozomenos et al., 1985) , while MAP1 A and 1B have been reported to be components of cross-bridges between MTs in IDPN-intoxicated rat axons (Hirokawa et al., 1985) . Purkinje cells in the cerebellar cortex develop characteristic dendrites, which have been favorite targets of investigations into the relationship between MTs and MAPS in neuronal tissue in vivo. However, the cytoskeletal architecture of dendrites has not been well understood, compared with that of axons (Hirokawa, 1982; Schnapp and Reese, 1982; Hirokawa et al., 1984 Hirokawa et al., , 1985 Hirokawa and Yorifuji, 1986) . Furthermore, it has not as yet been determined what functions these proteins perform in the construction of the cytoskeletal architecture in dendrites at the molecular level, although extensive immunofluorescent studies have been carried out on both MAP1 and MAP2.
In the present investigation we carried out immunoelectronmicroscopic studies using our anti-MAPlA monoclonal antibody (McAb) combined with the quick-freeze, deep-etch technique (QF-DE) on rat Purkinje cell dendrites. At the same time we studied the molecular structure of affinity-purified MAP1 A and the taxol-stabilized MTs decorated with MAP 1A. We found that dendrites consist of MTs and extensive networks of crossbridges and that MAP1 A is a long, thin, rodlike structure that is a major component of these cross-bridges between MTs in the dendrites.
Materials and Methods
Preparation of monoclonal antibody against MAPIA. We prepared a McAb anainst rat brain MAP1 A. MAP1 was vurified as an immunogen by the fillowing method. First, rat brain MTproteins were isolatedby the taxol procedure (Vallee, 1982) and subjected to preparative SDS-PAGE on a 7% polyacrylamide gel (Laemmli, 1970) . Then the MAP1 bands were excised from the gel and homogenized in 0.01 M phosphate buffer (pH 7.4). Homogenates containing MAP1 were stirred in the phosphate buffer with SDS (final concentration, 5%) overnight at room temperature in order to elute the protein from the gel, and then centrifuged at 10,000 rpm for 10 min at room temperature. The supernatant was recentrifuged at 30,000 rpm for 2 hr at room temperature. To precipitate the protein, cold acetone, -20°C was added to the supernatant at a concentration of over 70%, and this was incubated overnight at -20°C. Sediments were collected and cold acetone was added (at a final concentration of 70%). After centrifugation at 3000-5000 rpm for 5-10 min, pellets were resuspended in 70% acetone at 0°C. Finally, the pellets collected by centrifugation at 3000-5000 rpm were dialyzed in 0.0 1 M PBS and condensed.
To prepare a McAb, we injected the immunogen prepared by the above methods (MAP1 or MT proteins) intraperitoneally or into the footpads of BALB/c mice on 5 occasions. Three days after the final injection, immune lymphocytes from spleen and popliteal lymph nodes were collected and fused (Kohler and Milstein, 1976 ) with P3-X63-Ag8-653 mouse mveloma cells in a solution containing RPMI-1640 (Gibco Laboratories,-Grand Island, NY), 40% polyethylene glycol 200'0, and 20% dimethyl sulfoxide (DMSO). Cells were plated in 96-well tissue culture dishes, where they were maintained in HAT-selective medium for about a 2 week postfusion. Hybridomas were screened by the ELISA system, using MT proteins as the antigen, and by the immunoblotting method (Towbin et al.. 1979) . After limitina dilutions and screenings, we produced a single monoclone secreting anti-MAP1 McAb. The immunoreactive protein was identified on the nitrocellulose replica of the SDS gel (7% polyacrylamide) and on that of the SDS/urea gel (4% polyacrylamide) onto which rat brain crude extracts or MT proteins had been blotted.
Immunojluorescence microscopy. Cerebella were dissected from rats perfused with 2% paraformaldehyde and 0.1% glutaraldehyde in PEM buffer, pH 6.8 (100 mM piperazine N, N'-bis[2-ethanesulfonic acid] (PIPES), 1 mM EGTA, 1 mM MgCl,). Fixation was continued for an additional 2 hr in the same fixative at room temperature. Microslicer sections (40 Mm) were collected in 0.1 M phosphate buffer (pH 7.4) and processed iii&pension for immunofluorescence microscopy. Sections were preincubated overnight with 20% goat serum in 0.01 M PBS at 4°C in the presence of 0.25% Triton X-100 to block nonspecific staining, then incubated with undiluted primary antibody (culture medium of McAb. Rat brain crude extracts (lanes a, b, c) and rat brain microtubule proteins (lanes d, e, f) were subjected to SDS-PAGE on a 7% polyacrylamide gel. The positions ofMAP1, MAP2, and tubulin (7) were indicated. When high-molecularweight MAPS were separated in an SDS/urea gel (4% polyacrylamide), MAP1 and MAP2 were fractionated into MAP1 A, 1 B, 1 C, 2A, and 2B (lanes g, h, i). Bands of MAPIA, 2A, and 2B were indicated. Our McAb showed specific staining against MAP 1 (lanes b, e), and especially against MAPlA (lane h). Lanes a, d, and g were gels stained with Coomassie brilliant blue R250; lanes b, e, and h were nitrocellulose replicas stained with anti-MAP1 A McAb; lanes c, f; and i were nitrocellulose replicas stained with conditioned medium from myeloma cells.
anti-MAP1 A McAb or conditioned medium from myeloma cells as control) and with a second antibody (a fluorescein-conjugated IgG fraction ofgoat anti-mouse IgG) (Cappel Laboratories, Cochranville, PA) containine 0.025% Triton X-100 for 24-48 hr at 4°C. Stained sections were washed in PBS and mounted on glass slides with coverslips.
Electron-microscopic immunocytochemistry. The rat cerebellum was dissected out and incubated with 1% Triton X-100 in the fixative (2% varaformaldehyde, 0.1% glutaraldehyde, 10 I.IM taxol in PEM buffer, pH 6.8) for 40-min at room temperature. Samples were transferred to the fixative without Triton X-100 and fixed for a total of 2 hr. After rinsing with rinse buffer (4% sucrose in 0.1 M phosphate buffer, pH 7.4), the tissues were incubated with 1% NaBH, in rinse buffer, and then washed again thoroughly in rinse buffer.
Afterwards, the following incubation procedures for immunostaining were performed. The samples were incubated with 20% goat serum in Tris-buffer saline (TBS) (20 mM Tris, 0.9% NaCl), pH 7.6, for 3 hr at room temperature to block nonspecific reactions. Incubation with the first antibody (anti-MAP1 McAb or conditioned medium from myeloma cells) was continued for a total of 19 hr at room temperature and/ or at 4°C. The tissues were washed in TBS, pH 8.2, with 1% goat serum for 1 hr at room temperature, incubated with the second antibody (goldconjugated goat IgG anti-mouse IgG, 5nm) (Janssen Pharmaceutics, Beerse. Belgium) for a total of 19 hr. and then washed again in TBS, pH 8.2, with lo/d goat serum for 1 hr. After incubation with the second antibody, the samples were fixed and processed by a conventional procedure for electron microscopy (fixation: 1% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2; 1% 0~0, in 0.1 M sodium cacodylate buffer, pH 7.2; dehydration, and embedding in Epon 8 12).
Quick-freeze, deep-etch electron microscopy of Purkinje cell dendrites. In order to observe the 3-dimensional cytoskeletal ultrastructure of dendrites, we prepared fresh and saponiniextracted samples. Slices of rat cerebellum were incubated with 0.1% savonin in PEM buffer, vH 6.8, containing 0.3 mM phenylmethylsulfonyl fluoride, 1 mg/ml l&r-peptin, and 10 PM taxol, for 30 min at room temperature (Hirokawa, 1982) . Both fresh and saponin-extracted tissues were quick-frozen, freezefractured, deep-etched, and rotary-shadowed with platinum and carbon, as described previously (Heuser and Salpeter, 1979; Hirokawa and Heuser, 1981) .
Purijication of MAPlA. MAPlA was purified by a CNBr-activated Sepharose 4B column using McAb against MAP1 A. After application of the brain crude extracts, the column was washed with 0.0 1 M phosphate buffer containing 0.75 M NaCl and 0.5% Nonidet P-40. Bounded polypeptides were eluted with 3 M MgCl, in 0.1 M PEM buffer, peak fractions dialyzed in 20 mM PEM buffer, and were then subjected to PAGE (7% polyacrylamide and 4% SDS/urea polyacrylamide) to check their purity. Structures of MAPIA and taxol-stabilized MTs decorated with MAPIA.
The molecular structure of MAPlA was revealed by the rotary shadowing method (Tyler and Branton, 1980) . The solution of MAPlA with glycerol (at a final concentration of 60%) was sprayed onto pieces of freshly cleaved mica. Soon after, they were dried in vacua at room temperature for l-4 hr, rotary-shadowed with platinum (2.5 nm) at an angle of 6" and then overcoated with carbon. The structure of taxol-stabilized MT pellets composed of tubulin and MAPlA was studied by QF-DE. MTs decorated with MAPlA were prepared by the following method. Microtubule proteins from rat brains were purified by 3 cycles of temperature-dependent assembly and disassembly in PEM buffer, as described by Shelanski et al. (1973) . Tubulin was isolated from microtubule proteins by phosphocellulose chromatography under cold conditions, as described by Herzog and Weber (1978) . Pure tubulin was eluted with PEM buffer. The purified tubulin Figure 4. Higher magnification of a dendrite. MTs were connected to one another by filamentous projections or fuzzy materials (thin arrows) on which gold particles were specifically localized. x 76,000. Bar, 0.2 pm.
was incubated with affinity-purified MAPlA (at a quantitative ratio of 1: 1 to 8: 1) in PEM buffer at 37°C for 10 min by the addition of 1 mM GTP and 20 PM taxol. After centrifugation at 38,000 rpm at 30°C for 30 min, the pellets were processed for QF-DE. Thin sections and replicas were observed using a JEOL 1200EX EM at 100 kV. Results from calf brain white matter was separated into 3 bands of 1 A, lB, and lC, we found that MAP 1 A obtained from adult rat whole Anti-MAPlA monoclonal antibody brain was separated into 2 bands, and that the band of MAPlB When the blotted channels of unfractionated rat brain crude was hardly detectable, as shown in Fig. lg . Our McAb against extracts and MT proteins obtained by the taxol method were MAP1 reacted with 2 bands of MAP1 A (Fig. lh) . Figure 5 . Immunoelectron microscopy of a cross section of a dendrite. Gold particles were studded on fuzzy materials that projected from MTs. Most of these structures (arrows) cross-linked MTs to one another. x 57,000. Inset, Higher-magnification of a cross section. Immunogolds located on filamentous projections that connect MTs to one another. x 118,000. Bars, 0.2 pm. Immunofluorescence microscopy Our anti-MAP1 A McAb was examined immunofluorescently on the rat cerebellar cortex. Purkinje cell perikarya and dendrites were always stained brightly ( Fig. 2A) and, in some sections, we found Purkinje cell axons stained in the granule layer. These results coincided well with those of previous studies using anti-MAP1 antibodies (Matus et al., 1983; Bloom et al., 1984; Huber and Matus, 1984) .
Electron-microscopic immunocytochemistry
To localize MAP1 A within the dendritic cytoskeletons, we prepared slices of rat cerebellum extracted with Triton X-100 and labeled them with monoclonal anti-MAP1 A, followed with immunogold staining. Figure 3 shows a Purkinje cell dendrite labeled with anti-MAP1 A antibody. Purkinje cell dendrites were identified by the presence of the characteristic hypolemmal cisternae and postsynaptic thorns. Gold particles were found specifically within the dendrite, whereas we could hardly observe any gold particles in adjacent synapses. The particles were studded on the filamentous fuzzy materials attached to MTs or connecting MTs to one another, but they were not observed on those associated with NFs. We also found a few particles on the material between MTs and membrane organelles such as mitochondoria. Electron micrographs of a higher magnification (Fig. 4) and a cross section of a dendrite (Fig. 5 ) display more clearly the localization of most gold particles on the projecting portions of filamentous fuzzy materials between MTs. The inset in Figure 5 shows such filamentous structures connecting MTs to one another. The distribution of these gold particles within dendrites is shown in Table 1 . The data also indicated clearly that most of the gold particles labeled MT-associated cytoskeleta1 materials. Samples incubated with a control medium showed no staining (Fig. 6 ).
Quick-freeze, deep-etch electron microscopy Dendritic cytoskeletons were observed by QF-DE. Figure 7 presents a low-magnification view of a Purkinje cell dendrite in a fresh cerebellum. MTs were predominantly found in dendrites, with only a few NFs. Striking features revealed by QF-DE in the dendrites were the elaborate networks of cross-bridges between MTs. These cross-bridges, branching and anastomosing much more extensively than those in axons, not only linked MTs to one another, but also connected membrane organelles (MOs), or plasmalemma to MTs. Furthermore, this network of MT-associated cross-bridges completely filled the cytoplasm in the dendrites, in contrast to the axon. The axonal cytoskeleton was mainly composed of numerous neurofilament lattices and sparsely distributed microtubule bundles (Fig. 8) . The overall image of the anastomosing networks between MTs in the dendrites was sometimes granular in appearance, partly because of the attachment of globular materials. MTs were characterized by longitudinal arrays of protofilaments. Bumps were seen sporadically on the surface.
A higher-magnification view of a fresh dendrite (Fig. 9A) highlight the detailed structures of cross-bridges between MTs. Hypolemmal cistemae and endoplasmic reticulum were also cross-linked to MTs by filamentous, anastomosing cross-bridges. To circumvent the possibility that these structures were artifactual results of condensations or precipitations of soluble proteins during deep etching, we examined saponin-treated tissues from which soluble proteins had been extracted. As can be seen in Figure 9B , networks of cross-bridges were preserved in the saponin-extracted dendrite. Though the filamentous appearance of the cross-bridges was more pronounced than that of the fresh samples, the width of the cross-bridges was still sometimes irregular.
Purification of MAPIA
In order to match the results of immunoelectron microscopy with the cytoskeletal structures observed by QF-DE, we further investigated the molecular structure and the appearance of MAP1 A while attached to MTs in vitro. The purity of affinitypurified MAP1 A is shown in Figure 1OA . The results of PAGE indicated that only MAP 1 A was predominant in the fraction (Fig. lO,A,d,g ).
Structures of MAPlA and taxol-stabilized MTs decorated with MAPIA
The molecular structure of MAP 1 A obtained by the rotaryshadowing method revealed that several individual molecules were long, thin, filamentous structures (ranging from about 100 to 150 nm in length) possessing considerable flexibility (Fig.  1OB) . Some molecules extended only slightly, and others ap- Figure 7 . Low-magnification view of a quick-frozen, deep-etched Purkinje cell dendrite in a fresh cerebellum. MTs (large arrows) were predominantly found in a dendrite. MTs were linked to one another by elaborate networks of cross-bridges that sometimes branched and anastomosed. In addition, MTs were connected to MOs, NFs, or plasmalemma by the cross-bridges, which were somewhat granular in appearance. MO, Membrane organelle; PM, plasmalemma. x 9 1,000. Bar, 0.2 pm. peared to be shorter filaments that may perhaps have been only fragments of molecules (data not shown). MTs assembled in the presence of taxol with purified MAP1 A were observed by QF-DE. As demonstrated in Figure 11 , many thin, filamentous crossbridges, presumably MAP 1A molecules, cross-linked the MTs to one another. These samples were subjected to PAGE to insure that they contained only tubulin and MAP1 A (Fig. lOJ,e) . Thin, filamentous cross-bridges were not present on the MTs from which MAPS were extracted by high-salt treatment (data not shown; see the earlier report of Hirokawa et al., 1985) .
Discussion
We have demonstrated the single-molecular structure of MAPlA and clearly displayed its distribution in dendritic cytoskeletons at the molecular level for the first time. By immunoelectron microscopy, we have shown that fuzzy materials between MTs in Purkinje cell dendrites were heavily marked by our anti-MAP1 A McAb (Figs. 3-S) . The ultrastructural images observed by QF-DE revealed networks of extensive, elaborate cross-bridges within dendrites (Fig. 7) . To juxtapose the results of immunoelectron microscopy with the cytoskeletal structures observed by QF-DE, we performed a number of experiments in vitro. We examined the structures of the affinity-purified MAP1 A molecule and of MTs decorated with MAP 1 A. The MAP 1 A molecule took a long, thin, filamentous, and very flexible shape and formed filamentous cross-bridges between MTs when MAPlA and tubulin were incubated in the presence of taxol. These in vitro results indicated that MAP 1 A could be responsible for the presence of both fuzzy materials and cross-bridges in vivo. Consequently, we concluded that MAPlA was one of the major components of the elaborate network of cross-bridges between microtubules in Purkinje cell dendrites.
There are regional differences in the structures and chemical composition of neurons. In dendrites, abundant MTs are dis- tributed uniformly, with few neurofilaments. Axonal MTs, on bridges in dendrites branched and anastomosed more extenthe other hand, are generally organized into a MT domain of sively than those observed in axons, although some of their small, tightly packed clusters within abundant neurofdaments features were somewhat similar to those in the MT domain of (Hirokawa, 1982) . QF-DE, in this report, revealed the tremen-IDPN-intoxicated rat axons (Hirokawa et al., 1985) . dously elaborate network of cross-bridges that developed
Immunological (Miller et al., 1982; Matus et al., 1983 ; Bloom throughout the dendrites, filling up the spaces among MTs, and et al., 1984; DeCamilli et al., 1984; Peng et al., 1986 ) and biobetween MTs and MOs, and plasmalemma. MT-associated cross-chemical (Vallee, 1982; Peng et al., 1986 ) studies have revealed Figure 9 . A, Higher magnification of a fresh Purkinje cell dendrite. Cross-bridges (arrows) connected MTs to one another. Hc, Hypolemmal cistemae; ER, endoplasmic reticulum. x 190,000. B, High magnification of a saponin-extracted dendrite. After extraction by saponin, the structure of cross-bridges (arrow) was well preserved and their width was sometimes irregular. x 165,000. Bars (A. B), 0.1 pm. Figure 10 . A, MAPlA was purified by the affinity column with high efficiency. It was checked by PAGE on 7% polyacrylamide gels (lanes a, b, c, d, e) and by 4% SDS/urea polyacrylamide gels (lanes J; g). a, Rat brain MT proteins obtained by tax01 method (MAPl, MAP2, and tubulin, T, were indicated); b, rat brain crude extracts that were applied to the affinity column; c, flowthrough (note that the amount of MAPlA is markedly-decreased compared to the crude extracts); d, the peak fraction of MAP1 A eluted by 3 M MgCl, (in this fraction, only MAP1 was eluted): e, taxol-stabilized MT pellets decorated with affinity-purified MAPlA, f; MT proteins separated into MAPlA, lB, lC, 2A;and 2B (bands corresponding to MAPIA are indicated); g, affinity-purified MAP1 A. This gel indicated that the MAPlA was clearly purified. B, Molecular structures of MAPlA obtained by the rotary-shadowing method. Molecules have extended long, thin, flexible structures. ~214,000. Bar, 100 nm. the regional differences in the chemical components of neurons. For example, MAP1 exists equally in both axons and dendrites (Matus et al., 1983; Bloom et al., 1984; Huber and Matus, 1984; Peng et al., 1986) ; MAP2 is abundant in dendrites but scarcely exists in axons (Vallee, 1982; Papasozomenos et al., 1985) ; and tau is prominent in axons (Binder et al., 1984; Peng et al., 1986) . The regional differences in composition are likely responsible for the corresponding differences in structure.
We considered the possibility that MAP2, at least, was another component of the MT-associated cross-bridges in dendrites, because many investigators have reported that purified MAP2, a long, rodlike molecule (Voter and Erikson, 1982) , forms filamentous arms on the surface of MTs in vitro (Herzog and Weber, 1978; Kim et al., 1979; Murphy, 1983, 1985) . Probably MAP 1 and MAP2 have a structural interrelationship within the network of dendritic cross-bridges. This may explain the more complicated features of cross-bridges in dendrites than in axons.
There may be yet other molecules besides MAPlA and MAP2, such as those possibly responsible for the granular appearance of the cross-bridges observed in this study, and all of these molecules are presumed to be involved in the interactions of MTs with one another and with cellular components. In order to further clarify the functions of MTs and MAPS in dendrites in vivo, additional studies directed at the identification of each of the molecular components of the cross-bridges between MTs and MTs and with other cellular components need to be carried out.
